Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
52,283,523
-
Share change
-
+3,378,399
-
Total reported value
-
$7,587,950,162
-
Put/Call ratio
-
72%
-
Price per share
-
$145.13
-
Number of holders
-
302
-
Value change
-
+$512,523,733
-
Number of buys
-
138
-
Number of sells
-
152
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2017
As of 31 Mar 2017,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
302 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,283,523 shares.
The largest 10 holders included
PUTNAM INVESTMENTS LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JANUS CAPITAL MANAGEMENT LLC, Bank of New York Mellon Corp, WESTFIELD CAPITAL MANAGEMENT CO LP, ADAGE CAPITAL PARTNERS GP, L.L.C., CADIAN CAPITAL MANAGEMENT, LP, and FIL Ltd.
This page lists
302
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.